Panitumumab lacks efficacy in metastatic renal cancer?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1449, 2004-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Doxorubicin liposomal + docetaxel: efficacy in metastatic breast cancer?

By  

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Stem cell transplantation feasible for metastatic renal cancer?

By  

Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Abraxane the best taxane for metastatic breast cancer?

By  

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Bisphosphonates: are they useful in breast cancer?

By  

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Molecular-Targeting Revolution Advances into Renal Cancer: Is Sutent® the New Gold Standard for Metastatic Disease?

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 7, 2006-07 ,pp. : 8-10

Adis International

Access to resources Recommend Favorite